GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (OSTO:AZN) » Definitions » Inventories, Finished Goods

AstraZeneca (OSTO:AZN) Inventories, Finished Goods : kr0 Mil (As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is AstraZeneca Inventories, Finished Goods?

AstraZeneca's annual finished goods declined from Dec. 2021 (kr18,288 Mil) to Dec. 2022 (kr14,664 Mil) but then increased from Dec. 2022 (kr14,664 Mil) to Dec. 2023 (kr16,084 Mil).

AstraZeneca Inventories, Finished Goods Historical Data

The historical data trend for AstraZeneca's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Inventories, Finished Goods Chart

AstraZeneca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,290.75 11,967.60 18,288.28 14,664.11 16,083.92

AstraZeneca Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 16,083.92 - - -

AstraZeneca Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

AstraZeneca Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (OSTO:AZN) » Definitions » Inventories, Finished Goods
Comparable Companies
LSE:GSK LLY OCSE:NOVO B JNJ ABBV MRK XSWX:ROG XSWX:NOVN AMGN PFE XPAR:SAN BMY GILD TSE:4519 TSE:4568 SHSE:600276 TSE:4578 BIIB XTER:BAYN SHSE:600436
Traded in Other Exchanges
AZNCF:USA AZN:USA AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil ZEG:Bulgaria AZN:Argentina
Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
Website
https://www.astrazeneca.com
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.